Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending this week.

| More on:
Two colleagues at work looking at a tablet and smiling at a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many of Australia's top brokers have been busy adjusting their financial models again, leading to the release of a number of broker notes this week.

Three ASX shares brokers have named as buys this week are listed below. Here's why they are bullish on them:

Allkem Ltd (ASX: AKE)

According to a note out of Morgans, its analysts have upgraded this lithium miner's shares to an add rating with an improved price target of $15.30. This follows the release of a broad update on the company's operations. While Morgans has lifted its cost expectations for Allkem, the addition of the Cauchari operation into its model results in an increase in its valuation. In light of this and recent weakness, the broker believes the current share price represents a very attractive entry point for investors. The Allkem share price is trading at $11.33 today.

Lovisa Holdings Ltd (ASX: LOV)

A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $25.25 price target on this fashion jewellery retailer's shares. The broker believes that investors may be concerned by a sudden slowdown in store rollouts. However, it isn't worried and highlights Lovisa's huge long-term expansion opportunity. And while FY 2024 could be a subdued year for sales growth, Morgan Stanley expects a return to form the following year. The Lovisa share price is fetching $19.25 on Wednesday.

Pro Medicus Limited (ASX: PME)

Analysts at Goldman Sachs have reiterated their buy rating on this health imaging technology company's shares with an improved price target of $88. This follows the announcement of a huge contract win in the United States. Goldman has updated its estimates and is now forecasting operating earnings growth of 26%+ per annum through to FY 2026. This contract win supports its view of Pro Medicus being the clear incumbent technology leader in a growth market. The Pro Medicus share price is trading at $80.20 this afternoon.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group, Lovisa, and Pro Medicus. The Motley Fool Australia has recommended Lovisa and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man sits smiling at a computer showing graphs
Broker Notes

Morgans names more of the best ASX 200 shares to buy in December

These ASX 200 shares have been given the thumbs up by analysts at Morgans in December.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Broker Notes

Morgans names the best ASX 200 shares to buy in December

Morgans is expecting strong returns from these top ASX 200 shares over the next 12 months.

Read more »

A man sits at a desk holding a small replica house in his hand, upset at the sale of his property.
Real Estate Shares

The 2 ASX real estate shares everyone's piling on to right now

Property stocks have been rocketing the past few weeks, and these companies are the ones investors are flocking to.

Read more »

Miner and company person analysing results of a mining company.
Resources Shares

Buy or sell? Brokers argue best play for ASX 200 iron ore share, up 30% in 2 months

There are conflicting opinions among the experts.

Read more »

A person sitting at a desk smiling and looking at a computer.
Investing Strategies

'Ahead of expectations': Why this ASX stock could make you smile in a few years

Sometimes the stock price doesn't reflect the business performance. This is when long-term investors can pounce.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A young boy points and smiles as he eats fried chicken.
Share Gainers

'Double-digit earnings growth': 2 fast-rising ASX shares not too late to buy

Get on these stocks before all their potential is realised, say Celeste analysts. So what are you waiting for?!

Read more »